news
Roche to acquire TIB Molbiol Group to expand PCR-test portfolio
Roche signs a definitive share purchase agreement with TIB Molbiol Group to expand PCR-test portfolio against infectious diseases.
List view / Grid view
Zika virus
news
Novel HIV vaccine approach shows promise in “landmark” first-in-human trial
The vaccine was able to target the desired immune cells and could become the first stage of a multi-step vaccine strategy to combat HIV and various other viral diseases.
article
What the world can learn from the UK’s pharmaceutical industry
Through the recent coronavirus crisis, the UK’s pharmaceutical sector has performed strongly and delivered innovation at a time when it was most needed. In this article, Dr Cheryl Teoh discusses how the industry has been set up for success.
article
Developing a preventive vaccine regimen to tackle Ebola
Earlier this year, Johnson & Johnson announced the first major regulatory approval of a vaccine developed by Janssen for the prevention of Ebola. Nikki Withers spoke with the Global Head of Vaccines, Johan Van Hoof, to discover what technologies were used and how they are now being leveraged to develop…
news
Investigational Zika vaccine receives Fast Track designation
An investigational Zika vaccine currently being evaluated in a Phase I study has been given a Fast Track designation by the FDA.
news
Report suggests process for vaccine trials during health crises
A recent report has presented an argument for updating vaccine development during health emergencies to increase efficiency.
news
Radiance could be the key to faster viral detection
Viruses explored through Radiance, an instrument designed to improve the process of analysis, ensures quick and efficient viral detection...
news
Rapid Zika detection test uses smartphone technology
Leveraging nanoparticles and digital health technology, BWH investigators develop rapid, deployable, low-cost diagnostic test for Zika virus
news
New uses for existing antiviral drugs
A test of 55 antiviral drugs that are known to be safe in humans found 7 compounds that show new effects against multiple viruses...
news
Zika vaccine candidate receives FDA fast track designation
The FDA has granted Fast Track designation to TAK-426, Takeda’s purified, inactivated, alum-adjuvanted, whole Zika virus vaccine candidate...
news
Sofosbuvir found to be effective against Zika virus
A drug used to treat Hepatitis C effectively protected and rescued neural cells infected by the Zika virus...
news
Anti-malaria drug shows promise as Zika virus treatment
Chloroquine found to reduced the amount of Zika virus in maternal blood and neural progenitor cells in the foetal brain
news
Integrated lab-on-a-chip uses smartphone to detect multiple pathogens
Researchers have developed a platform to diagnose infectious diseases at the point-of-care, using a smartphone as the detection instrument...
news
Zika Virus assay for screening blood donations
23 May 2017 | By Niamh Marriott, Junior Editor
Grifols now provides European countries accepting products with the CE marking with a test to detect the presence of the Zika virus in donated blood.
news
FDA approves Abbott’s molecular Zika virus test
3 February 2017 | By Niamh Marriott, Digital Editor
The US Food and Drug Administration (FDA) has authorised Abbott’s molecular test to detect Zika virus in whole blood (when collected alongside a patient-matched serum or plasma sample) for emergency use. This is the first molecular test made by a commercial manufacturer authorised to detect Zika in whole blood samples;…
